Delivery Order SPE2DB24D8001-SPE2DB25FKYXC

Award Date 12/5/24
Potential Completion Date 12/6/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB25FKYXC
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The contract, with a ceiling value of $2,846.52, is a firm fixed price delivery order contract that runs through December 6, 2024.

Dakota Drug, Inc. is the prime contractor for this award and holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which enables the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This particular delivery order falls under that broader IDC contract vehicle. The contract does not have a set-aside designation.

Generated 3/6/25, 10:11 AM